Thomas Zimmermann - Publications

Lipoprotein apheresis in the era of new lipid-lowering therapies.

Journal: European heart journal

Published: October 16, 2025

The German Lipoprotein Apheresis Registry-Summary of the eleventh annual report.

Journal: Atherosclerosis

Published: March 23, 2024

The German Lipoprotein Apheresis Registry-Summary of the ninth annual report.

Journal: Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy

Published: August 22, 2021

Lipoprotein apheresis is an optimal therapeutic option to reduce increased Lp(a) levels.

Journal: Clinical research in cardiology supplements

Published: March 07, 2019

Current insights into the German Lipoprotein Apheresis Registry (GLAR) - Almost 5 years on.

Journal: Atherosclerosis. Supplements

Published: November 04, 2017

Erratum to: The German Lipoprotein Apheresis Registry (GLAR) - almost 5 years on.

Journal: Clinical research in cardiology supplements

Published: July 19, 2017

The German Lipoprotein Apheresis Registry (GLAR) - almost 5 years on.

Journal: Clinical research in cardiology supplements

Published: February 25, 2017

First data from the German Lipoprotein Apheresis Registry (GLAR).

Journal: Atherosclerosis. Supplements

Published: May 05, 2015

Impact of the German Lipoprotein Apheresis Registry (DLAR) on therapeutic options to reduce increased Lp(a) levels.

Journal: Clinical research in cardiology supplements

Published: February 06, 2015